Relay Therapeutics | IPO Presentation Deck

The slide uses a comparison between validated industry successes and the remaining addressable market to frame the investment opportunity.size_opportunity

Open slide detailBeat · Market Sizing

The slide uses a visual contrast between protein structure and lab work to frame the problem.frame_problem

Open slide detailBeat · ProblemLoop · Cost Of Inaction

The slide uses a funnel-like diagram to show convergence over time from 1990 to 2020.argue_timing

Open slide detailLoop · Why Now

The background is a repeating pattern of chemical structures. The central image is a protein model.present_solution

Open slide detailBeat · Solution

The slide uses a Venn diagram to show the intersection of Experimentation and Computation.present_solution

Open slide detailBeat · Solution

transition

Open slide detail

The slide uses a standard pharmaceutical pipeline Gantt-style chart.plan_implementation

Open slide detailLoop · Quick Win Big Bet

The slide uses a biological pathway diagram to explain the mechanism of action and lists tumor types to define the market segment.size_opportunity

Open slide detail

The table highlights the limitations of current pan-FGFR inhibitors (Pemigatinib, Infigratinib, TAS-120, Erdafitinib) regarding hyperphosphatemia and discontinucompare_peers

Open slide detailBeat · Competitive Analysis

Uses a visual comparison framework to illustrate the superiority of their proprietary technology in protein visualization.present_solution

Open slide detail

Includes preclinical data comparing RLY-4008 to Pemigatinib, Infigratinib, and TAS-120.present_solution

Open slide detail

The slide uses a process flow diagram to illustrate the clinical trial structure (Part 1 and Part 2) mapped against a 2020-2022 timeline.plan_implementation

Open slide detail

The slide uses a before-after framing: the left side shows the biological problem (pathway signaling), and the right side shows the solution (a library of optimpresent_solution

Open slide detail

Waterfall plots showing tumor volume change in xenograft models.present_solution

Open slide detail

plan_implementation

Open slide detail

The slide uses a combination of a bar chart to show market opportunity and a Kaplan-Meier survival curve to show clinical efficacy, followed by a list of toxiciframe_problem

Open slide detail

Lower bars indicate higher potency (as potency is measured in µM, lower values are better).compare_peers

Open slide detail

The slide uses a before-after-framing style to contrast efficacy and side-effect profiles.show_traction

Open slide detail

transition

Open slide detail

The slide uses a split-layout to contrast operational progress with financial health.plan_implementation

Open slide detailBeat · Financials

The slide uses a grid layout for headshots and logos to establish credibility through team and investor pedigree.other

Open slide detail

The slide uses a circular process diagram to connect the company's funding to its operational milestones.show_traction

Open slide detail